Budget Amount *help |
¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2017: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2016: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2015: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Outline of Final Research Achievements |
MASL, a lectin-derived from Maackia amurensis, can work as a therapeutic agent on psoriasis via regulation of podoplanin-expression and the function. The precise functional mechanism has not been fully elucidated. However, results acquired in this study and safety of oral MASL administration to mice in previous reports suggest the possibility of MASL as a novel therapeutic option for the treatment of psoriasis.
|